Reproducible dsRNA Microinjection and Oviposition Bioassay in Mosquitoes and House Flies
November 8th, 2018
12.2K views
This protocol describes a microinjection methodology that we have standardized and used for several years to deliver specific quantities of nucleic acids directly to the hemolymph of mosquitoes and house flies. This protocol results in minimal injection mortality and allows dose correlated measurements of fecundity.
Overview
This protocol describes a standardized microinjection methodology for delivering nucleic acids to the hemolymph of mosquitoes and house flies. It minimizes injection mortality and allows for dose-correlated measurements of fecundity.
Key Study Components
Area of Science
- Entomology
- Genetics
- Biopesticide research
Background
- Microinjection is a technique used to introduce substances directly into cells or organisms.
- This method is particularly useful for studying gene expression and fecundity in dipterans.
- Double strand RNA can impact gene expression in target species.
- Mastering the injection technique requires practice and precision.
Purpose of Study
- To evaluate the effects of double strand RNA on gene expression in mosquitoes and house flies.
- To assess the impact of microinjection on fecundity and multi-generational lethality.
- To provide a detailed protocol for researchers in the field.
Methods Used
- Preparation of injection solutions with specific concentrations.
- Microinjection of nucleic acids into the hemolymph of staged insects.
- Monitoring recovery and oviposition of injected females.
- Assessment of gene expression and fecundity post-injection.
Main Results
- Significant reduction in gene expression was observed in injected females.
- Average clutch sizes were notably decreased in treated groups.
- Demonstrated dose-dependent effects on fecundity across multiple cycles.
- Injection success was critical for accurate data collection.
Conclusions
- The microinjection method is effective for delivering RNA to study gene function.
- Results indicate potential for using this technique in biopesticide development.
- Further research can expand applications to other insect species.
Frequently Asked Questions
What is the main advantage of this microinjection technique?
The main advantage is the ability to deliver quantifiable doses of double strand RNA directly to the target insects, allowing for precise assessments of gene expression and fecundity.
Can this method be applied to other insect species?
Yes, while the protocol is demonstrated for Aedes aegypti and Musca domestica, it can be adapted for other species of mosquitoes and flies.
What are the critical factors for successful microinjection?
Using the optimal needle tip size and mastering the injection technique are crucial to minimize injury and ensure successful delivery of the solution.
How does the injection affect the fecundity of the insects?
The injection of double strand RNA has been shown to significantly reduce the average clutch sizes in treated female mosquitoes across multiple oviposition cycles.
What preparations are needed before starting the microinjection?
Insects should be staged properly, and the injection solution must be prepared with the correct concentration and visualization aids.
How is the success of the injection assessed?
Success is assessed by observing meniscus movement during injection and ensuring no solution beads out of the cuticle upon needle removal.
Executive Industry Relevance
Accurate dosing of nucleic acids is essential for evaluating biopesticide mechanisms and phenotypic outcomes in insect vectors. This protocol enables quantitative delivery of dsRNA to support dose-response analysis and cross-compound comparison in early-stage target validation. By reducing injection-associated mortality and standardizing fecundity readouts, it improves predictive confidence in mechanistic de-risking efforts for vector control programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of gene function through quantifiable dsRNA delivery to assess phenotypic effects on fecundity.
- Operational Value: Reduces variability from injection injury, improving reproducibility of gene knockdown measurements across studies.
Screening & Assay Development
- Scientific Value: Supports preparation of dose-response curves by enabling precise microinjection of defined dsRNA concentrations.
- Operational Value: Facilitates standardized compound screening through visual verification via Rhodamine B and consistent injection site targeting.
Translational & Preclinical Research
- Scientific Value: Provides a disease-relevant system for assessing multi-generational lethality and fecundity reduction in vector species.
- Operational Value: Enables continuity from target hit validation to preclinical efficacy testing through oviposition bioassay integration.
Pipeline & Workflow Integration
The method fits within early discovery workflows where target hypothesis testing requires measurable phenotypic outputs in whole organisms.
- Discovery Biology: Supports target validation by linking dsRNA delivery to measurable reductions in gene expression and reproductive output.
- Screening: Enables assay readiness through quantifiable dosing and low-mortality recovery protocols that support replicate testing.
- Analytics: Generates quantitative dependent variable measurements (clutch size, gene expression) that allow statistical comparison of compound efficacy.
- Translational Research: Connects mechanism to phenotype via fecundity assessment, supporting risk-adjusted advancement decisions in vector control pipelines.
- Enterprise Reuse: Establishes a reusable platform for dsRNA delivery across mosquito and fly species, reducing redevelopment costs in vector control programs.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target mechanism through dose-correlated phenotypic readouts.
- Operational Value: Standardization and reproducibility via graduated needles, visual tracers, and defined recovery conditions.
- Strategic Value: Improved go/no-go decisions by enabling reliable comparison of dsRNA constructs based on fecundity impact.
- Portfolio Impact: Risk-adjusted prioritization of vector control candidates through fecundity-based efficacy thresholds.
Implementation Considerations
- Requires expertise in microinjection techniques and insect handling under cold anesthesia.
- Dependence on calibrated microinjectors, glass capillary preparation, and visualization tools like Rhodamine B.
- Need for standardized post-injection recovery and oviposition environments to ensure consistent fecundity scoring.
- Adaptation considerations across species due to variations in needle size and injection site anatomy.
- Practical limitations include manual injection throughput and dependency on operator skill for consistent delivery.
Biopharma FAQs
Why does quantifiable dsRNA delivery matter for target validation?
Quantifiable delivery ensures that observed phenotypic effects, such as reduced fecundity, are directly attributable to specific dsRNA doses rather than variable injection efficiency. This enables accurate dose-response modeling and reliable comparison between different nucleic acid constructs in target validation workflows.
How does isolating the independent variable (dsRNA dose) improve discovery pipeline efficiency?
By controlling dsRNA concentration and minimizing confounding factors like injection injury, the method isolates the effect of gene silencing on phenotypic outcomes. This increases confidence in target mechanism attribution and reduces false positives during early-stage screening.
What quantitative dependent variable measurements enable efficacy assessment?
The protocol measures clutch size and gene expression levels as dependent variables to quantify the biological impact of dsRNA treatment. These metrics allow researchers to calculate effective doses and compare potency across different targets or constructs.
Why are replication requirements important for cross-functional collaboration?
Replication ensures that fecundity and gene expression results are consistent across operators, batches, and insect strains, which is essential for handing off data between discovery, toxicology, and field testing teams. Standardized recovery and oviposition protocols support this reproducibility.
What statistical analysis capabilities are required before implementing this assay?
Teams must be able to perform dose-response analysis and compare clutch size or gene expression means across treatment groups using appropriate statistical tests. This requires access to quantitative output data and software capable of evaluating significance and effect size in biological replicates.
Chapters in this video
0:04
Title
0:53
Insect Preparation
1:21
Insect Injection
3:57
Aedes aegypti Mortality and Oviposition Bioassay
5:22
Musca domestica Mortality and Oviposition Bioassay
7:08
Results: Microinjection with dsRNA Leads to Reduced Specific Transcript Expression and Clutch Size in Aedes aegypti and Musca domestica
8:10
Conclusion
